Most courses are eight weeks long: two eight-week courses taken consecutively in the fall semester, two eight-week courses in the spring semester, and one eight-week course in the summer semester of year one.
The MS in Medical Cannabis Science and Therapeutics program blends online instruction with face-to-face experiences at the Universities at Shady Grove, located in Rockville, Md. The program is designed to be completed in two years.
Students will take five required foundational courses in medical cannabis science, therapeutics, and policy. Students will also be able to choose four elective courses based on their interests. After completing elective courses. In addition to these courses, students will take a one-credit course based on the fall and spring symposiums in year one, and two one-credit capstone courses in year two.
Terminal Performance Objectives:
- Apply knowledge of pharmacology, pathophysiology, clinical assessment, and traditional management strategies of pain and other physical symptoms to identify appropriate candidates for medical cannabis therapy.
- Apply concepts of pharmacology, pharmacognosy, pharmaceutics, and pharmacokinetics to determine appropriate cannabis dosing, dosage forms and routes of administration for optimal treatment.
- Develop monitoring plans to determine effectiveness of medical cannabis therapy and to detect adverse effects of medical cannabis use.
- Apply concepts of analytical chemistry, pharmacology, pharmacognosy, and pharmaceutics to assure safe and effective design, development, and manufacture of medical cannabis products.
- Apply knowledge of analytical toxicology methods to identify, quantify, and interpret results related to cannabinoid use and misuse.
- Describe negative physical, psychiatric, and psychosocial effects of cannabis in individuals and populations.
- Participate in health policy decision-making processes by evaluating primary literature to assist policy makers and prescribers in making well-informed decisions about medical cannabis therapy.
- Apply knowledge of historical and current laws, regulations, and policies to identify, analyze, and advocate for emerging issues related to medical cannabis and health.
- Identify areas for future research related to science, health effects, and policy of medical cannabis, and describe the challenges associated with such research.
- Demonstrate a commitment to excellence through continuing professional development and the education and training of patients, healthcare professionals, regulatory bodies, and other relevant stakeholders.
Suggested Plan of Study for the Cohort Entering in Fall 2021 and Beyond:
|Year||Semester||Course Number||Credits||Course Name|
|1||Fall A||MCST 601||3||Introduction to Medical Cannabis History, Culture, and Policy|
|1||Fall B||MCST 602||3||Principles of Drug Action and Cannabinoid Pharmacology|
|1||Spring A||MCST 604||3||The Clinical Effects of Medical Cannabis|
|1||Spring B||MCST 603||3||Basic Cannabinoid Chemistry and Drug Delivery|
|1||Fall/Spring||MCST 613||1||Medical Cannabis Symposium|
|2||Fall A||MCST 607||3||Negative Physical, Psychiatric, and Social Effects of Cannabis|
|2||Fall A/B||MCST 614||1||Medical Cannabis Capstone I|
|2||Fall B||3||Elective 2*|
|2||Spring A||3||Elective 3*|
|2||Spring B||3||Elective 4*|
|2||Spring A/B||MCST 615||1||Medical Cannabis Capstone II|
* Cohort of students entering fall of 2021 and beyond must choose to take four of the possible elective courses:
- MCST 605: Advanced Cannabis Therapeutics for Somatic Conditions
- MCST 606: Advanced Neuropsychiatric Cannabis Therapeutics
- MCST 608: Cannabis Genomics and Pharmacognosy
- MCST 609: Advanced Cannabinoid Chemistry and Analytic Testing Methodology
- MCST 610: State and Federal Cannabis Laws and Policies
- MCST 611: Research Design and Medical Cannabis
- MCST 616: Medical Cannabis Advocacy
- MCST 617: Introduction to Integrative Health and Wellness